Bruker (BRKR) Misses Q3 EPS by 1c; Guides Slightly Below the Street

Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.14, $0.01 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $419.8 million versus the consensus estimate of $436.3 million.

Bruker sees FY2014 EPS of $0.72-$0.78, versus the consensus of $0.8. Bruker sees FY2014 revenue of $1.81-1.84 billion, versus the consensus of $1.86 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• CareDx completes Naveris acquisition, adding cancer MRD testing
• Netflix gains over 3% as report refutes NBCUniversal acquisition speculation